Terazosin-d8 [CAS 1006718-20-2]

Terazosin-d8 is deuterium labeled Terazosin. Terazosin is a quinazoline derivative and a competitive and orally active α1-adrenoceptor antagonist. Terazosin works by relaxing blood vessels and the opening of the bladder. Terazosin has the potential for benign prostatic hyperplasia (BPH) and high blood pressure treatment[1][2][3].

[1006718-20-2]

C19H17D8N5O4

395.48

NC1=NC(N2C([2H])([2H])C([2H])([2H])N(C([2H])([2H])C2([2H])[2H])C(C3CCCO3)=O)=NC4=C1C=C(OC)C(OC)=C4

Adrenergic Receptor; Isotope-Labeled Compounds

99.23

10 mM in DMSO

-20°C, 3 years (Powder)

Blue Ice